Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy
Status:
Not yet recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
- Reduce the trauma and the time taken for patient rehabilitation.
- The prevailing trend is to perform a mitomycin- C (MMC)-augmented trabeculectomy and
trabeculectomy with ologen implants in a trial to decrease bleb failure as a common
post- trabeculectomy complication.
- Is to develop a measurement protocol by OCT-A imaging and characterization of the bleb
vascularity changes in glaucoma patients before and after surgery.